• ELP-Mediated p21 Peptide Delivery Suppresses Glioblastoma Gr

  2026-06-01

  The referenced study demonstrates that elastin-like polypeptide (ELP)-mediated intracellular delivery of a p21-derived peptide effectively inhibits proliferation in diverse glioblastoma cell lines, mainly through cytostatic rather than apoptotic mechanisms. These findings highlight the promise of ELP-based platforms to overcome delivery barriers and target cell cycle dysregulation in aggressive brain tumors.

• Sulfachloropyridazine: Deep Dive into Microbiota Modulation

  2026-06-01

  Explore how the sulfonamide antibacterial agent Sulfachloropyridazine modulates microbial communities and informs advanced research protocols. Uncover scientific insights and practical recommendations for antimicrobial susceptibility and microbiome studies.

• Baicalin: Pathway Modulation for Translational Neuroplastici

  2026-05-31

  Explore how Baicalin, a flavone glycoside from Scutellaria baicalensis, pioneers translational neuroplasticity by modulating KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3 pathways. This thought-leadership article provides mechanistic insight, validation from recent amblyopia research, and strategic workflow guidance for researchers leveraging APExBIO's high-purity Baicalin.

• Predicting Major Bleeding Risk During Extended Anticoagulati

  2026-05-30

  This study introduces and validates a new clinical model (CHAP) for predicting major bleeding in patients with unprovoked or weakly provoked venous thromboembolism (VTE) receiving extended anticoagulation. Its findings support the use of both modified existing scores and CHAP for risk stratification, informing clinical decisions on anticoagulation duration.

• TK1 in Endometrial Carcinoma: Expression, Prognosis, and Cel

  2026-05-29

  This study provides a comprehensive analysis of thymidine kinase 1 (TK1) in uterine corpus endometrial carcinoma (UCEC), revealing its upregulation, clinical correlations, and mechanistic links to cell cycle regulation. The findings clarify TK1's prognostic value and its potential as a biomarker for disease progression and treatment monitoring.

• VX-765: Potent Caspase-1 Inhibitor for Inflammation Research

  2026-05-29

  VX-765 empowers researchers with highly selective caspase-1 inhibition, enabling precise dissection of IL-1β and IL-18 signaling in inflammation and pyroptosis models. Its robust solubility and pharmacological profile streamline workflows for both in vitro and in vivo studies, with proven translational impact in autoimmune and infectious disease research.

• Aconitase Activity Colorimetric Assay Kit: Reliable TCA Cycl

  2026-05-28

  This article examines real laboratory challenges in measuring mitochondrial and cytosolic aconitase activity, highlighting how the Aconitase Activity Colorimetric Assay Kit (SKU K2226) from APExBIO delivers reproducibility, sensitivity, and workflow efficiency. Scenario-driven Q&As address conceptual, experimental, and comparative aspects, guiding biomedical researchers and technicians toward robust metabolic and oxidative stress quantification.

• Mitomycin C: Applied Protocols for Antitumor Antibiotic Rese

  2026-05-28

  Mitomycin C's unique DNA cross-linking mechanism makes it indispensable for apoptosis signaling and translational cancer workflows. This guide translates recent research and expert troubleshooting into actionable, bench-ready protocols to maximize reproducibility and performance in advanced oncology models.

• (+)-Bicuculline: Technical Use and Workflow Practicalities

  2026-05-27

  (+)-Bicuculline is a classical GABAA receptor antagonist used to dissect inhibitory neurotransmission and support studies on synaptic NMDA receptor signaling modulation in neuroscience research. It is not suited for diagnostic, clinical, or therapeutic applications, and its reliable use requires strict adherence to solubility and storage protocols. This guide details actionable protocol and workflow considerations based on product-specific data.

• α-Amanitin in Transcriptional Regulation Research: Protocols

  2026-05-27

  α-Amanitin, a selective RNA polymerase II inhibitor from APExBIO, is revolutionizing transcriptional regulation research with unmatched specificity and reproducibility. Discover advanced experimental protocols, troubleshooting insights, and real-world applications that empower researchers to dissect gene expression pathways and developmental models with precision.

• TNF-alpha Recombinant Murine Protein in Apoptosis Research

  2026-05-26

  Harness TNF-alpha recombinant murine protein to dissect apoptosis and inflammation pathways with exceptional reproducibility and mechanistic clarity. This guide delivers actionable workflows, advanced troubleshooting, and novel insights from RNA Pol II inhibition studies—empowering your cell death modeling with APExBIO’s trusted reagent.

• Biotin-XX Tyramide Reagent: Shaping Cell Surface Proteomics

  2026-05-26

  Discover how Biotin-XX Tyramide Reagent empowers next-generation cell surface proteomics, enabling precise, membrane-impermeant labeling for advanced signal amplification. This article reveals unique insights from recent neuroscience breakthroughs and practical assay design.

• JZL184: Monoacylglycerol Lipase Inhibitor for Neuroprotectio

  2026-05-26

  JZL184 enables precise manipulation of endocannabinoid signaling in models of neuropathology, pain, and cognitive dysfunction. Its exceptional selectivity as a monoacylglycerol lipase inhibitor makes it indispensable for dissecting CB1 receptor-mediated pathways and optimizing translational workflows in neuropharmacology research.

• Caspase-8 Activation in Hyperthermia and Cisplatin-Induced C

  2026-05-25

  The referenced study reveals that combining hyperthermia with cisplatin therapy enhances cancer cell death by promoting caspase-8 accumulation, K63-linked ubiquitination, and activation. This mechanistic insight underscores the centrality of caspase-8 in orchestrating both apoptosis and pyroptosis, providing a rationale for improved combination therapies and targeted apoptosis assay strategies.

• High-Throughput Discovery of TB DHFR Inhibitors and MoA Insi

  2026-05-24

  Santa Maria et al. introduce a scalable framework that links high-throughput phenotypic and biophysical screens with machine learning to elucidate mechanisms of action (MoA) and identify novel inhibitors of Mycobacterium tuberculosis dihydrofolate reductase (DHFR). This integrative method advances antibacterial agent discovery by improving target validation and offering actionable pathways for tuberculosis research.

449 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page